Partner Therapeutics announced initiation of clinical trial to evaluate Leukine in patients with COVID-19
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
-
-
Biotechnology | FDA | Oncology | Therapeutics
Partner Therapeutics acquired Sanofi’s Leukine and Lynnwood manufacturing facility
On Mar. 9, 2018, Boston-based cancer company Partner Therapeutics announced that it has acquired the global rights to develop,…
